Summary.-The sera of 73 patients with nasopharyngeal carcinoma (NPC), 28 patients with other carcinomas (OC) and 89 healthy subjects (HS) were tested for IgG and IgA antibodies to Epstein-Barr virus (EBV) viral capsid antigen (VCA). The majority of the NPC sera had IgG titres of 160 or above, whereas the majority of the other sera had titres below 160. For IgA reactivity to EBV-VCA,68 of 73 (93*2%) NPC sera had titres of > 10. In contrast, only 6 of 28 (21-4%) OC sera and none of the HS sera had such titres. The mean serum concentrations of IgG, IgA, IgM and C3' were also determined in 55 NPC and 20 OC patients and 18 HS. They were all significantly higher in the NPC sera than in the HS. Although the concentrations of IgG and C3' were not significantly different in the two carcinoma groups, the concentrations of IgA and IgM were significantly higher in the NPC group than in OC. These findings appear to reflect the intensity of EBV-specific antigenic stimulation in NPC, and the EBV-specific serum IgA reactivity may be a useful aid to the diagnosis of NPC, especially in cases with an occult primary tumour. It may be also of value as a screening test in people at high risk.
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AN ASSOCIATION of the Epstein-Barr virus (EBV) with nasopharyngeal carcinoma (NPC) is now firmly established. Old et al. (1966) first demonstrated the presence of precipitating antibodies to EBV-related antigens in sera from patients with the cancer. This discovery was followed by the demonstration that NPC patients in widely separated parts of the world had higher geometric mean titres (GMT) of antibodies to EB viral capsid antigen (VCA) than those of control groups, made up of patients with other head and neck cancers and normal subjects (de Schryver et al., 1969 (de Schryver et al., . 1974 Henle et al., 1970; Lin et at., 1971; Henderson et al., 1974; Desgranges et al., 1975) . The GMT of antibodies to VCA increases with advancing clinical stage of the disease Henle et al., 1970 Henle et al., , 1973 de-The et al., 1975) . de-The et al. (1975) ) and 28 patients with other carcinomas (OC) (14 bronchus, 9 head and neck, 2 cervix, 2 urinary bladder and 1 rectum) and from a group of 89 healthy adult subjects (HS) consisting of 27 volunteers, 44 blood donors and 18 patients due for discharge from traumatic wards of Queen Elizabeth Hospital.
Sera were routinely stored in small aliquots at -70°C until used. IgG anti-VCA titres were determined according to the method of Henle and Henle (1966) and reacting cell smears prepared from Jijoye cell line with diluted serum aliquots and counter-stained with fluorescein-conjugated (FITC) goat antihuman IgG (Dako, Copenhagen). The results were expressed as the reciprocal of the maximum serum dilution giving positive fluorescent staining of the cell smears. To detect IgA anti-VCA, sera were diluted 1: 10 with PBS, and similarly reacted with the Jijoye cell smears, which were then counterstained with FITC goat anti-human IgA (Dako, Copenhagen) .
Serum immunoglobulin and complement C3' concentrations were estimated in some of the sera by the radial immuno-diffusion method (Mancini et al., 1964) (Glaser, 1976) and by BUdR to express EBV particles (Trumper et al., 1976) , it is conceivable that the almost exclusively high frequency and titres of EBV-specific IgA in NPC might be derived locally in response to the tumour. Ho ( , 1972a to have an increased risk.
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